09 May 2005 BHRC Benzene Health Research Consortium Draft Conference Call Minutes Scientific & Ethics Review Panels (SRP/ERP) o October conference call/Munich Benzene meeting o Exxon/Mobil contributions to on-site staffing/advisory activities: Chinese Speaker and industrial hygienist (Yimei Zhou) Consultant familiar with benzene issues and with China (Gary Krieger) Since the report was issued, budget-based responsibility/ownership for Exposure Assessment elements has been resolved and delineated Helmut Greim noted that Fudan's Progress Report honestly identified problems and proposed solutions ilt'mm: Dick Albertini requests clarification of "clinical physical" group ilt'mm: confirm that PI inter-communication has improved Richard Irons (DP & ME) YE2004 Progress Report Rich Irons noted that case accrual expectations should be met by Dec. 2006 Harvey Checkoway asked about SRP/ERP review of manuscripts (topic deferred to later in this call) Report states that ME phase 2(b) will be collapsed into ME2(a) olllliimN: Request clarification from Dr.

To: benzene-erp@ listserve. api. org <benzene-erp@ listserve. api. org>; benzene- srp@listserve.api.org <benzene-srp@listserve.api.org> From: Bruce Jarnot <jarnotb@api.org> Cc: Matt Todd <ToddM@api.org>; Robin Tillery <tilleryr@api.org> Bcc: Received Date: 2006-02-1318:30:23 GMT Subject: SHS-ERP & -SRP...

Study ID Number _ _ _ __ Name _ _ __ Interview START TIME_ _ _ __ Part 1.

UCHSC-Fudan University Health Effects Data System backup and recovery.

CC/DP Exposure Assessment for PROBABLE "BENZENE" EXPOSED ;:;()~"/(?

DRAFT Shanghai Health Study Funding Structure Current SHS funders (as of Oct. 2002): BP ConocoPhillips ChevronTexaco ExxonMobil Shell Chemical API administers the SHS. $22.8 million program total for all costs: operations for five years estimated to identify case studies; staff training, data collection and analysis; study revisions recommended by the scientific and ethics panels; patient privacy protections; constructing a state-of-the-art laboratory at Fudan University in China; and laboratory operations for research and clinical tests. $16.5 million is currently funded.

Verified study diagnoses of approximately: o 500-600 cases of AML o 400-500 cases ofNHL Follow-up of Disease Progression through 12/31/07 Continued maintenance of the JCML Tissue Bank and formal transition of the Tissue Bank to ICMRC.

To: ellen.w.clayton@vanderbilt.edu <ellen.w.clayton@vanderbilt.edu>; jarnotb@api.org <jarnotb@api.org>; benzene-erp@listserve.api.org <benzene-erp@listserve.api.org>; benzene- srp@listserve.api.org <benzene-srp@listserve.api.org> From: Jmricewas@aol.com <Jmricewas@aol.com> Cc: Bcc: Received Date: 2004-08-27 15:49:00 GMT Subject: Re: SRP & ERP....

DRAFT CINPATHOGEN DELIVERABLES d.

I also took the opportunity to network with some key stakeholders plus senior companies reps present and summarised the key pOints below for your ref: It I talked to the BP rep [Regional Chief Medical Officer] who advised that he felt that organisation was poor and that it was an opportunity missed.

To: 'tortmj@cpchem.com' <tortmj@cpchem.com>; 'DGHUNT@DOW.COM' <DGHUNT@DOW.COM>; 'claude.white@equistarchem.com' <claude.white@equistarchem.com>; Clegg, Patsy M SCC-DCS/22 <patsy.clegg@shell.com>; 'Marcy.Banton@Lyondell.com' <Marcy.Banton@Lyondell.com>; 'jsbus@dow.com' <jsbus@dow.com> From: Cagen, Stuart Z SHLOIL-SHOIL-SHS </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=SC724012> Cc: 'jarnotb@api.org' <jarnotb@api.org>; 'michael.g.bird@exxonmobil.com' <michael.g.bird@exxonmobil.com> Bcc: Received Date: 2006-02-1718:15:05 GMT Subject: FW: Yes!

To: brian.e.doll@exxonmobil.com <brian.e.doll@exxonmobil.com>; Matt Todd <ToddM@api.org> From: Clegg, Patsy M SCC-CHSE-PC </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: benzconsort-oc@ listserve. api. org <benzconsort-oc@ listserve. api. org> Bcc: Received Date: 2005-10-1912:07:00 GMT Subject: RE: BHRC: Timeline and Letter Review I am catching up from being out of the office for a few days.

To: Mark Fitzsimmons (E-mail)<mfitzsim@steptoe.com> From: Clegg, Patsy M SCC-DCS/22 </o=SHE LUou=MSXSCC/cn=Recipientslcn=PH197432> Cc: Bcc: Received Date: 2007-01 -05 13:00: 00 GMT Subject: FW: an issue related to Dr.

To: Snyder, Phil J SCC-DCS/2 <phil.snyder@shell.com>; Williams, Elizabeth J SCAI- DCS/22 <elizabeth.williams@shell.com> From: Clegg, Patsy M SCC-DCS/22 </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Bcc: Received Date: 2007-03-0303:24:33 GMT Subject: API letters Phil; I sent the Shell letter to Jennifer Galvin.

SHANGHAI HEALTH STUDY Main Messages As part of their ongoing individual product stewardship and safety and health programs, a consortium of petroleum and chemical companies is sponsoring a scientifically rigorous research project to further the current understanding of the human health effects of benzene.